1 |
Takahashi, H. and Parsons, P. G. (1990) In vitro phenotypic alteration of human melanoma cells induced by differentiating agents: heterogeneous effects on cellular growth and morphology, enzymatic activity, and antigenic expression. Pigment Cell Res. 3, 223-232.
DOI
|
2 |
Toyofuku, K., Wada, I., Valencia, J. C., Kushimoto, T., Ferrans, V. J. and Hearing, V. J. (2001) Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. FASEB J. 15, 2149-2161.
DOI
ScienceOn
|
3 |
Wilkins, L., Gilchrest, B. A., Szabo, G., Weinstein, R. and Maciag, T. (1985) The stimulation of normal human melanocyte proliferation in vitro by melanocyte growth factor from bovine brain. J. Cell Physiol. 122, 350-361.
DOI
|
4 |
Wong, G. and Pawelek, J. (1975) Melanocyte-stimulating hormone promotes activation of pre-existing tyrosinase molecules in Cloudman S91 melanoma cells. Nature 255, 644-646.
DOI
|
5 |
Lan, C. C., Chen, G. S., Chiou, M. H., Wu, C. S., Chang, C. H. and Yu, H. S. (2005) FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo. Br. J. Dermatol. 153, 498-505.
DOI
|
6 |
Maeda, K., Naganuma, M., Fukuda, M., Matsunaga, J. and Tomita, Y. (1996) Effect of pituitary and ovarian hormones on human melanocytes in vitro. Pigment Cell Res. 9, 204-212.
DOI
|
7 |
Lee, J., Jung, E., Park, J., Park, E., Kim, J., Hong, S., Park, J., Park, S. and Park, D. (2005) Glycyrrhizin induces melanogenesis by elevating a cAMP level in b16 melanoma cells. J. Invest. Dermatol. 124, 405-411.
DOI
|
8 |
Lee, J., Jung, K., Kim, Y. S. and Park, D. (2007) Diosgenin inhibits melanogenesis through the activation of phosphatidylinositol-3-kinase pathway (PI3K) signaling. Life Sci. 81, 249-254.
DOI
|
9 |
Ma, D., Zhang, J., Sugahara, K., Sagara, Y. and Kodama, H. (2001) Effect of sarsasapogenin and its derivatives on the stimulus coupled responses of human neutrophils. Clin. Chim. Acta. 314, 107-112.
DOI
|
10 |
Ren, L. X., Luo, Y. F., Li, X. and Wu, Y. L. (2007) Antidepressant activity of sarsasapogenin from Anemarrhena asphodeloides Bunge (Liliaceae). Pharmazie 62, 78-79.
|
11 |
Riley, P. A. (1997) Melanin. Int. J. Biochem. Cell Biol. 29, 1235-1239.
DOI
ScienceOn
|
12 |
Schallreuter, K. U., Hasse, S., Rokos, H., Chavan, B., Shalbaf, M., Spencer, J. D. and Wood, J. M. (2009) Cholesterol regulates melanogenesis in human epidermal melanocytes and melanoma cells. Exp. Dermatol. 18, 680-688.
DOI
|
13 |
Scott, G. A., Jacobs, S. E. and Pentland, A. P. (2006) sPLA2-X stimulates cutaneous melanocyte dendricity and pigmentation through a lysophosphatidylcholine-dependent mechanism. J. Invest. Dermatol. 126, 855-861.
DOI
|
14 |
Hunt, G., Todd, C., Cresswell, J. E. and Thody, A. J. (1994) Alpha-melanocyte stimulating hormone and its analogue Nle4DPhe7 alpha- MSH affect morphology, tyrosinase activity and melanogenesis in cultured human melanocytes. J. Cell Sci. 107, 205-211.
|
15 |
Kim, D. S., Kim, S. Y., Park, S. H., Choi, Y. G., Kwon, S. B., Kim, M. K., Na, J. I., Youn, S. W. and Park, K. C. (2005) Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. Biol. Pharm. Bull. 28, 2216-2219.
DOI
ScienceOn
|
16 |
Ito, A., Tanaka, C., Takeuchi, T. and Mishima, Y. (1991) Glucocorticoid stimulates melanogenesis and tyrosinase gene expression in B16 melanoma cells. Pigment Cell Res. 4, 247-251.
DOI
|
17 |
Jeon, S., Kim, N. H., Koo, B. S., Lee, H. J. and Lee, A. Y. (2007) Bee venom stimulates human melanocyte proliferation, melanogenesis, dendricity and migration. Exp. Mol. Med. 39, 603-613.
DOI
ScienceOn
|
18 |
Jimenez-Cervantes, C., Solano, F., Kobayashi, T., Urabe, K., Hearing, V. J., Lozano, J. A. and Garcia-Borron, J. C. (1994) A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole- 2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J. Biol. Chem. 269, 17993-18000.
|
19 |
Kobayashi, N., Nakagawa, A., Muramatsu, T., Yamashina, Y., Shirai, T., Hashimoto, M. W., Ishigaki, Y., Ohnishi, T. and Mori, T. (1998) Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. J. Invest. Dermatol. 110, 806-810.
DOI
|
20 |
Kovacs, S. O. (1998) Vitiligo. J. Am. Acad. Dermatol. 38, 647-666.
DOI
ScienceOn
|
21 |
Krasagakis, K., Garbe, C., Kruger-Krasagakes, S. and Orfanos, C. E. (1993) 12-O-tetradecanoylphorbol-13-acetate not only modulates proliferation rates, but also alters antigen expression and LAK-cell susceptibility of normal human melanocytes in vitro. J. Invest. Dermatol. 100, 653-659.
DOI
|
22 |
Cabanes, J., Chazarra, S. and Garcia-Carmona, F. (1994) Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of catecholase activity of tyrosinase. J. Pharm. Pharmacol. 46, 982-985.
DOI
ScienceOn
|
23 |
Halaban, R., Ghosh, S. and Baird, A. (1987) bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev. Biol. 23, 47-52.
DOI
|
24 |
del Marmol, V. and Beermann, F. (1996) Tyrosinase and related proteins in mammalian pigmentation. FEBS Lett. 381, 165-168.
DOI
ScienceOn
|
25 |
Fuller, B. B., Drake, M. A., Spaulding, D. T. and Chaudhry, F. (2000) Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. J. Invest. Dermatol. 114, 268-276.
DOI
ScienceOn
|
26 |
Grabbe, J., Welker, P., Dippel, E. and Czarnetzki, B. M. (1994) Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch. Dermatol. Res. 287, 78-84.
DOI
ScienceOn
|
27 |
Halaban, R., Pomerantz, S. H., Marshall, S. and Lerner, A. B. (1984) Tyrosinase activity and abundance in Cloudman melanoma cells. Arch. Biochem. Biophys. 230, 383-387.
DOI
|
28 |
Hearing, V. J. (2000) The melanosome: the perfect model for cellular responses to the environment. Pigment Cell Res. 13 Suppl 8, 23-34.
DOI
|
29 |
Hosoi, J., Abe, E., Suda, T. and Kuroki, T. (1985) Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res. 45, 1474-1478.
|
30 |
Hu, Y., Xia, Z., Sun, Q., Orsi, A. and Rees, D. (2005) A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-defi cit rat models. Brain Res. 1060, 26-39.
DOI
|
31 |
Bertolotto, C., Busca, R., Abbe, P., Bille, K., Aberdam, E., Ortonne, J. P. and Ballotti, R. (1998b) Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol. Cell Biol. 18, 694-702.
|
32 |
Applezweig. (1987) Treatment of obesity and diabetes using sapogenins. US4680289.
|
33 |
Bao, W., Pan, H., Lu, M., Ni, Y., Zhang, R. and Gong, X. (2007) The apoptotic effect of sarsasapogenin from Anemarrhena asphodeloides on HepG2 human hepatoma cells. Cell Biol. Int. 31, 887-892.
DOI
|
34 |
Bertolotto, C., Abbe, P., Hemesath, T. J., Bille, K., Fisher, D. E., Ortonne, J. P. and Ballotti, R. (1998a) Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J. Cell Biol. 142, 827-835.
DOI
ScienceOn
|
35 |
Birlea, S. A., Costin, G. E. and Norris, D. A. (2009) New insights on therapy with vitamin D analogs targeting the intracellular pathways that control repigmentation in human vitiligo. Med. Res. Rev. 29, 514-546.
DOI
|